Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults; [Análisis de costes y de coste/eficacia de las pautas recomendadas por GESIDA/Plan Nacional so

ANTONIO RIVERO ROMÁN2026-01-292026-01-29201710.1016/j.eimc.2016.06.0132-s2.0-85008354458https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27762Infectious DiseasesMicrobiologyMicrobiology (medical)Infectious DiseasesMicrobiologyMicrobiology (medical)Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults; [Análisis de costes y de coste/eficacia de las pautas recomendadas por GESIDA/Plan Nacional soresearch article